Nilotinib Benefits Relapsed Patients With CML After Treatment Discontinuation Targeted Oncology 2:03 5 years ago 1 910 Далее Скачать
NeoSep1: An innovative trial to improve antibiotic treatment for neonatal sepsis | SNIP-AFRICA Penta Child Health Research 3:09 8 days ago No Далее Скачать
RECOURSE Trial: Phase III trial: The Onset of Neutropenia as a Treatment Response Indicator Oncology.TV 3:51 7 years ago 68 Далее Скачать
Considering a Myelofibrosis Clinical Trial? Questions You Should Ask Patient Empowerment Network 5:02 5 months ago 15 Далее Скачать
Dr. Cortes on the 192-Week Follow-Up Results of the ENESTop Trial in CML OncLive 2:00 5 years ago 95 Далее Скачать
Overview of the CLLR3 trial of obinutuzumab VJHemOnc – Video Journal of Hematology & HemOnc 1:39 7 years ago 93 Далее Скачать
Neutrodiet trial: comparing infections using NRD and PD in patients with neutropenia after HSCT VJHemOnc – Video Journal of Hematology & HemOnc 4:18 1 year ago 89 Далее Скачать
Update on ENESTop: TFR in CML after discontinuing nilotinib VJHemOnc – Video Journal of Hematology & HemOnc 2:36 6 years ago 263 Далее Скачать
Utilizing Pathologic Complete Response in Breast Cancer Trials OncLive 5:55 9 years ago 686 Далее Скачать